Frontiers in Stem Cell and Organoid Medicine Symposium Returns Virtually March 24-25
Post Date: March 2, 2022 | Publish Date:
The third Frontiers in Stem Cell and Organoid Medicine Symposium will be held virtually March 24-25 with a line-up of global thought leaders in the field, including top academic researchers, industry scientists, and junior investigators.
Co-sponsors of this translational stem cell research conference include The Center for Stem Cell & Organoid Medicine (CuSTOM) and RIKEN Center for Biosystems Dynamics Research (BDR) as well as several leading biotechnology and pharmaceutical companies.
The international symposium will focus on basic research, clinical and commercial translation of pluripotent stem cell and organoid technology, accelerating academic-industry partnerships and more.
Discussion panels will feature experts from academia, industry, and the FDA.
This year’s keynote presentations will feature Gordon Keller, PhD, director of the McEwan Stem Cell Institute at the University Health Network in Toronto, and Lorenz Studer, MD, founder and director of the Center for Stem Cell Biology at the Memorial-Sloan Kettering Cancer Center in New York City.
Keller is the premier researcher, worldwide, in the application of developmental biology-guided principles to the differentiation of pluripotent stem cells into therapeutically relevant cells, such as cardiomyocytes, hematopoietic cells and liver cells. In addition to his position at the McEwen Stem Cell Institute, Keller is a senior scientist at The Princess Margaret Cancer Centre, a professor at the University of Toronto’s Department of Medical Biophysics as well as a founding Board member of the International Society of Stem Cell Research.
Studer is a developmental biologist and neuroscientist who is pioneering the generation of midbrain dopamine neurons for transplantation and clinical applications. In 2015, he received a MacArthur Fellowship “Genius Grant” for his innovative work on stem cell and Parkinson’s disease research. Currently, he is a member of the Developmental Biology Program and Department of Neurosurgery at Memorial Sloan-Kettering Cancer Center and a professor of Neuroscience at Weill Cornell Medical College in New York City.
Other presenters include:
- Louis Borlado, PhD, Takeda
- Alan Burns, PhD, Takeda
- Leyla Esfandiari, PhD, CuSTOM, University of Cincinnati
- Mingxia Gu, MD, PhD, CuSTOM, Cincinnati Children’s
- Ziyuan Guo, PhD, CuSTOM, Cincinnati Children’s
- Michael Helmrath, MD, MS, CuSTOM, Cincinnati Children’s
- Deborah Hursh, PhD, Center for Biologics Evaluation and Research (CBER), FDA
- Karl Koehler, PhD, Boston Children’s Hospital
- Darrell Kotton, MD, Boston University
- Hidetoshi Masumoto, MD, PhD, RIKEN Center for Biosystems Dynamics Research, Japan
- Mitsuru Morimoto, PhD, RIKEN Center for Biosystems Dynamics Research, Japan
- Sergiu Pasca, MD, Stanford University School of Medicine
- Josef Penninger, MD, University of British Columbia, Canada
- Oksana Sirenko, PhD, Molecular Devices
- Li Qian, PhD, University of North Carolina
- Adrian Roth, Prof. Dr, Roche, Switzerland
- Toshiro Sato, MD, PhD, Keio University, Japan
- Mark Skylar-Scott, PhD, Stanford University School of Medicine
- Minoru Takasato, PhD, RIKEN Center for Biosystems Dynamics Research, Japan
- Yo Tanaka, PhD, RIKEN Center for Biosystems Dynamics Research, Japan
- James Wells, PhD, CuSTOM, Cincinnati Children’s
- Susanne Wells, PhD, CuSTOM, Cincinnati Children’s
- Kelley Yan, MD, Columbia University
- Aaron Zorn, PhD, CuSTOM, Cincinnati Children’s
Registration for this two-day virtual symposium is $50 for academic attendees and free for trainees including students and fellows. Click here to register by March 11, 2022. After registering, you will receive a confirmation email with additional information.
For questions, please contact CuSTOM@cchmc.org.
